CrossLife Technologies is a biotechnology research firm that develops molecular diagnostics kits for diagnosing infectious diseases.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jun 12, 2017 | Grant | $224.92K | 1 | National Science Foundation | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
National Science Foundation | Yes | Grant |